Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Suppression of stromal interferon signaling by human papillomavirus type 16.

Raikhy G, Woodby BL, Scott ML, Shin G, Myers JE, Scott RS, Bodily JM.

J Virol. 2019 Jul 10. pii: JVI.00458-19. doi: 10.1128/JVI.00458-19. [Epub ahead of print]

PMID:
31292244
2.

Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.

Guidry JT, Myers JE, Bienkowska-Haba M, Songock WK, Ma X, Shi M, Nathan CO, Bodily JM, Sapp MJ, Scott RS.

J Virol. 2019 Jan 4;93(2). pii: e01216-18. doi: 10.1128/JVI.01216-18. Print 2019 Jan 15.

3.

Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.

Scott ML, Coleman DT, Kelly KC, Carroll JL, Woodby B, Songock WK, Cardelli JA, Bodily JM.

Virology. 2018 Jun;519:1-11. doi: 10.1016/j.virol.2018.03.021. Epub 2018 Mar 31.

4.

A new cell culture model to genetically dissect the complete human papillomavirus life cycle.

Bienkowska-Haba M, Luszczek W, Myers JE, Keiffer TR, DiGiuseppe S, Polk P, Bodily JM, Scott RS, Sapp M.

PLoS Pathog. 2018 Mar 1;14(3):e1006846. doi: 10.1371/journal.ppat.1006846. eCollection 2018 Mar.

5.

Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.

Woodby BL, Songock WK, Scott ML, Raikhy G, Bodily JM.

J Virol. 2018 Mar 28;92(8). pii: e01714-17. doi: 10.1128/JVI.01714-17. Print 2018 Apr 15.

6.

Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

Songock WK, Scott ML, Bodily JM.

Virology. 2017 Jul;507:179-191. doi: 10.1016/j.virol.2017.04.021. Epub 2017 Apr 24.

7.

The human papillomavirus E7 oncoprotein as a regulator of transcription.

Songock WK, Kim SM, Bodily JM.

Virus Res. 2017 Mar 2;231:56-75. doi: 10.1016/j.virusres.2016.10.017. Epub 2016 Nov 8. Review.

8.

Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1).

Dykes SS, Gao C, Songock WK, Bigelow RL, Woude GV, Bodily JM, Cardelli JA.

Mol Carcinog. 2017 Feb;56(2):722-734. doi: 10.1002/mc.22528. Epub 2016 Aug 22.

9.

Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.

Klymenko T, Hernandez-Lopez H, MacDonald AI, Bodily JM, Graham SV.

J Virol. 2016 Apr 29;90(10):5047-58. doi: 10.1128/JVI.03073-15. Print 2016 May 15.

10.

The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes.

Langsfeld ES, Bodily JM, Laimins LA.

PLoS Pathog. 2015 Sep 25;11(9):e1005181. doi: 10.1371/journal.ppat.1005181. eCollection 2015 Sep.

11.

Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication.

Gauson EJ, Donaldson MM, Dornan ES, Wang X, Bristol M, Bodily JM, Morgan IM.

J Virol. 2015 May;89(9):4980-91. doi: 10.1128/JVI.00335-15. Epub 2015 Feb 18.

12.

Genetic methods for studying the role of viral oncogenes in the HPV life cycle.

Bodily JM.

Methods Mol Biol. 2015;1249:81-91. doi: 10.1007/978-1-4939-2013-6_6.

PMID:
25348299
13.

Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle.

Bodily JM, Hennigan C, Wrobel GA, Rodriguez CM.

Virology. 2013 Aug 15;443(1):11-9. doi: 10.1016/j.virol.2013.04.033. Epub 2013 May 29.

14.

An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment.

Donaldson MM, Mackintosh LJ, Bodily JM, Dornan ES, Laimins LA, Morgan IM.

J Virol. 2012 Dec;86(23):12806-15. doi: 10.1128/JVI.01002-12. Epub 2012 Sep 12.

15.

The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle.

Bodily JM, Mehta KP, Cruz L, Meyers C, Laimins LA.

J Virol. 2011 Sep;85(17):8852-62. doi: 10.1128/JVI.00664-11. Epub 2011 Jun 22.

16.

Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases.

Bodily JM, Mehta KP, Laimins LA.

Cancer Res. 2011 Feb 1;71(3):1187-95. doi: 10.1158/0008-5472.CAN-10-2626. Epub 2010 Dec 8.

17.

Enucleation of feeder cells and egg cells with psoralens.

McGarry TJ, Bonaguidi M, Lyass L, Kessler JA, Bodily JM, Doglio L.

Dev Dyn. 2009 Oct;238(10):2614-21. doi: 10.1002/dvdy.22080.

18.

Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.

Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M, Laimins LA.

Virology. 2009 May 10;387(2):442-8. doi: 10.1016/j.virol.2009.02.036. Epub 2009 Mar 24.

19.

Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C.

Bodily JM, Alam S, Meyers C.

Virology. 2006 May 10;348(2):328-40. Epub 2006 Feb 28.

20.

Analysis of HPV transcription by RPA.

Bodily JM, Meyers C.

Methods Mol Med. 2005;119:279-90.

PMID:
16350407
21.

Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium.

Alam S, Bromberg-White J, McLaughlin-Drubin M, Sen E, Bodily JM, Meyers C.

Anticancer Res. 2005 Mar-Apr;25(2A):765-77.

22.
23.

Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent.

Bromberg-White JL, Sen E, Alam S, Bodily JM, Meyers C.

J Virol. 2003 Oct;77(20):10975-83.

24.

The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas.

Bodily JM, Hoopes DJ, Roeder BL, Gilbert SG, Pettit GR, Herald CL, Rollins DN, Robison RA.

Cancer Lett. 1999 Feb 8;136(1):67-74.

PMID:
10211941

Supplemental Content

Loading ...
Support Center